These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8872795)

  • 1. Assessment of drug efficacy using home self-blood pressure measurement: the SMART study. Self Measurement for the Assessment of the Response to Trandolapril.
    Zannad F; Vaur L; Dutrey-Dupagne C; Genès N; Chatellier G; Elkik F; Ménard J
    J Hum Hypertens; 1996 Jun; 10(6):341-7. PubMed ID: 8872795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Home self blood pressure measurement in general practice. The SMART study. Self-measurement for the Assessment of the Response to Trandolapril.
    Chatellier G; Dutrey-Dupagne C; Vaur L; Zannad F; Genès N; Elkik F; Ménard J
    Am J Hypertens; 1996 Jul; 9(7):644-52. PubMed ID: 8806976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term effects of withdrawing angiotensin converting enzyme inhibitor therapy on home self-measured blood pressure in hypertensive patients.
    Vaur L; Bobrie G; Dutrey-Dupagne C; Dubroca I; Vaisse B; d'Yvoire MB; Elkik F; Chatellier G; Menard J
    Am J Hypertens; 1998 Feb; 11(2):165-73. PubMed ID: 9524044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of three blood pressure measurement methods for the evaluation of two antihypertensive drugs: feasibility, agreement, and reproducibility of blood pressure response.
    Ragot S; Genès N; Vaur L; Herpin D
    Am J Hypertens; 2000 Jun; 13(6 Pt 1):632-9. PubMed ID: 10912746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive effects of trandolapril and nitrendipine in the elderly: a controlled trial with special emphasis on time effect profiles.
    Zannad F; Vaur L; Dutrey-Dupagne C; Genes N; Clerson P
    J Hum Hypertens; 1996 Jan; 10(1):51-5. PubMed ID: 8642191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Once-daily monotherapy with trandolapril in the treatment of hypertension.
    Smith DH; Neutel JM; Black HR; Schoenberger JA; Weber MA
    J Hum Hypertens; 1996 Feb; 10(2):129-34. PubMed ID: 8867568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
    Tytus RH; Burgess ED; Assouline L; Vanjaka A
    Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring.
    Lacourcière Y; Neutel JM; Davidai G; Koval S
    Am J Hypertens; 2006 Jan; 19(1):104-12. PubMed ID: 16461201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Duration of action of trandolapril in mild to moderate hypertensive patients evaluated by ambulatory measurement of blood pressure].
    Kownator S; Dutrey-Dupagne C; Vaur L; Chevrier J; Diesel J; D'Hotel R; Schaaf R; Courvoisier A; Breton C
    Therapie; 1994; 49(2):89-93. PubMed ID: 7817355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits of electronic pillboxes in evaluating treatment compliance of patients with mild to moderate hypertension.
    Mallion JM; Dutrey-Dupagne C; Vaur L; Genes N; Renault M; Elkik F; Baguet P; Boutelant S
    J Hypertens; 1996 Jan; 14(1):137-44. PubMed ID: 12013487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of home pressure monitoring in the treatment hypertension in the practice of general medicine].
    Widimský J; Balazovjech I; Lánská V
    Vnitr Lek; 1999 Oct; 45(10):569-77. PubMed ID: 10951863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure levels, risk factors and antihypertensive treatments: lessons from the SHEAF study.
    Mallion JM; Genès N; Vaur L; Clerson P; Vaïsse B; Bobrie G; Chatellier G
    J Hum Hypertens; 2001 Dec; 15(12):841-8. PubMed ID: 11773986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Demonstration of differences in the effect of 2 antihypertensive agents by self blood pressure measurement: comparison of trandolapril and perindopril].
    Bobrie G; Dutrey-Dupagne C; Vaur L; Dubroca I; Elkik F; Chatellier G; Ménard J
    Therapie; 1997; 52(3):187-93. PubMed ID: 9366102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure control rates with an antihypertensive regimen including trandolapril in a Canadian usual-care setting.
    Tytus RH; Assouline L; Vanjaka A
    Adv Ther; 2011 Sep; 28(9):789-98. PubMed ID: 21850512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and duration of action of the four selective angiotensin II subtype 1 receptor blockers, losartan, candesartan, valsartan and telmisartan, in patients with essential hypertension determined by home blood pressure measurements.
    Nishimura T; Hashimoto J; Ohkubo T; Kikuya M; Metoki H; Asayama K; Totsune K; Imai Y
    Clin Exp Hypertens; 2005 Aug; 27(6):477-89. PubMed ID: 16081340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of benazepril monotherapy to amlodipine plus benazepril in the treatment of patients with mild and moderate hypertension: a multicentre, randomized, double-blind, parallel-controlled study].
    Fan CM; Yan LR; Tao YK; Wang L; Li YQ; Gao MM; Wang YN; Li CX; Wang XW; Lu XL; Pang HM; Li YS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Jan; 39(1):57-60. PubMed ID: 21418799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: the Iberian Multicenter Imidapril Study on Hypertension (IMISH).
    Palma Gámiz JL; Pêgo M; Contreras EM; Anglada MP; Martínez JO; Esquerra EA; Sagastagoitia Gorostiza JD;
    Clin Ther; 2006 Dec; 28(12):2040-51. PubMed ID: 17296460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The TEAM study--a study of the effectiveness and tolerance of treatment of essential hypertension with a fixed combination of trandolapril and verapamil].
    Widimský J; Dzúrik R
    Vnitr Lek; 1998 Jun; 44(6):326-31. PubMed ID: 9820054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.